Astrazeneca Plc

Astrazeneca Plc

Share this profile

We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

Products & Services

We have transformed our pipeline and returned to growth and, as a result of continued pipeline delivery and commercial execution, we are now entering a new stage of our journey. This is focused on enhanced innovation and the delivery of life-changing medicines that contribute value to patients and society.

The fundamentals of our strategy are clear. We focus on innovative science and leadership in our three main therapy areas: Oncology; Cardiovascular, Renal and Metabolism; and Respiratory diseases. Backed by a global presence, with strength in Emerging Markets, particularly China, we have a portfolio of specialty and primary care medicines.

At the same time, the world around us is changing and the burden of disease is increasing. We are responding by increasing our focus on growth through innovation – being more patient-centric, doing more with technology, digital and data, and advancing more cutting-edge science.
All this is reflected in our three strategic priorities.

Contact Information

Astrazeneca Plc